UnitedHealthcare
Ocaliva (obeticholic acid)
Drugs for the Liver : Drugs for the Liver
  • Primary Biliary Cirrhosis and Hepatic Fibrosis:
    Duration: 6 Month(s)
    Specialist Required: Yes
    Medical Test Required: Yes
    Specialist Type(s): 1 of Gastroenterologist;Hepatologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    How Many Tests are Required to Confirm Diagnosis: N/A
    Alkaline Phosphatase (ALP) Level Required: Unspecified
    Total Bilirubin Required: N/A
    Patient Must Not Have Clinically Significant Hepatic Decompensation: No
    Inadequate Response to Ursodiol Can Not Be Due to Non-Compliance: No
    Policy states the patient must not have other liver disease that is not related to PBC: No
    Must Not Have Complete Biliary Obstruction: No
    Concomitant Use of Ursodiol Required: Yes
    Duration of Ursodiol Without Adequate Response: = 12 month(s)
    Patient Must Not Be Experiencing Severe Pruritis: No
    Reauthorization Supporting Documentation Requirements: 1 of Chart Notes;Medical Tests
    Documented Diagnosis: Yes

  • Step Therapy: Primary Biliary Cirrhosis and Hepatic Fibrosis:
    ST Single Generic

  • Prior Authorization: Primary Biliary Cirrhosis and Hepatic Fibrosis:
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Duration: 6 Month(s)
    Reauthorization Required: Yes

  • Quantity Limit: limit maximum 1 EA PER 1 day(s)